Immunologically active polypeptide

Disclosed are immunomodulatory polypeptides that behave as weak TLR2 and TLR4 agonists and as potent competitive antagonists of natural pathogenic ligands for human and murine TLR2 and TLR4, that identify a subset of neutrophils in human peripheral blood leukocytes, and that elicit an unusual induce...

Full description

Saved in:
Bibliographic Details
Main Author Scoville, Craig D
Format Patent
LanguageEnglish
Published 30.07.2019
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Disclosed are immunomodulatory polypeptides that behave as weak TLR2 and TLR4 agonists and as potent competitive antagonists of natural pathogenic ligands for human and murine TLR2 and TLR4, that identify a subset of neutrophils in human peripheral blood leukocytes, and that elicit an unusual induced cytokine profile. Also disclosed are compositions comprising such polypeptides, compositions comprising antibodies that specifically bind to such polypeptides, and methods of using the same, including for treating sepsis or reducing the severity or likelihood of occurrence of sepsis, in cancer treatment, in the treatment of autoimmune diseases, in organ transplantation and for reducing graft rejection, for promoting fertility, and for identifying a neutrophil subset and/or other cellular subset including by flow cytometry. Pharmaceutical compositions and kits, and treatment methods are also disclosed.
AbstractList Disclosed are immunomodulatory polypeptides that behave as weak TLR2 and TLR4 agonists and as potent competitive antagonists of natural pathogenic ligands for human and murine TLR2 and TLR4, that identify a subset of neutrophils in human peripheral blood leukocytes, and that elicit an unusual induced cytokine profile. Also disclosed are compositions comprising such polypeptides, compositions comprising antibodies that specifically bind to such polypeptides, and methods of using the same, including for treating sepsis or reducing the severity or likelihood of occurrence of sepsis, in cancer treatment, in the treatment of autoimmune diseases, in organ transplantation and for reducing graft rejection, for promoting fertility, and for identifying a neutrophil subset and/or other cellular subset including by flow cytometry. Pharmaceutical compositions and kits, and treatment methods are also disclosed.
Author Scoville, Craig D
Author_xml – fullname: Scoville, Craig D
BookMark eNrjYmDJy89L5WRQ8szNLc3Lz8lPz0xOzMmpVEhMLsksS1UoyM-pLEgtKMlMSeVhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJqXmpJfGhwYYGxmamRuamTkbGxKgBANlGKJU
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
Physics
ExternalDocumentID US10365275B2
GroupedDBID EVB
ID FETCH-epo_espacenet_US10365275B23
IEDL.DBID EVB
IngestDate Fri Jul 19 13:03:14 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US10365275B23
Notes Application Number: US201414775499
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190730&DB=EPODOC&CC=US&NR=10365275B2
ParticipantIDs epo_espacenet_US10365275B2
PublicationCentury 2000
PublicationDate 20190730
PublicationDateYYYYMMDD 2019-07-30
PublicationDate_xml – month: 07
  year: 2019
  text: 20190730
  day: 30
PublicationDecade 2010
PublicationYear 2019
RelatedCompanies Institute of Arthritis Research, LLC
Institute of Arthritis Reasearch, LLC
RelatedCompanies_xml – name: Institute of Arthritis Reasearch, LLC
– name: Institute of Arthritis Research, LLC
Score 3.2151003
Snippet Disclosed are immunomodulatory polypeptides that behave as weak TLR2 and TLR4 agonists and as potent competitive antagonists of natural pathogenic ligands for...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HUMAN NECESSITIES
HYGIENE
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PHYSICS
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
TESTING
Title Immunologically active polypeptide
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190730&DB=EPODOC&locale=&CC=US&NR=10365275B2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1ZS8NAEB5KPeqbRkXrQRTJW1CS3aR5CEIuqtAD20jfSvYoKKUNTUT8906WxPqir7Owx7DzzXyzO7sAd4y4rsOchcmRUJtEUG5m6AhMxm0pCfMsRqva4cHQ6afkeUZnLXhvamHUO6Gf6nFEtCiO9l4qvM63SaxI3a0s7tkbitaPydSPjJodo3fDHWtEgR-PR9EoNMLQTyfG8AVjXduhlksDhOsdDKPdyhri16CqSsl_u5TkEHbH2NuqPIKWXGnQCZuf1zTYH9QH3hrsqRuavEBhbYXFMdw-VUUdDWotv_RMgZaer5fIKhEDhDyBmySehn0Th53_rHGeTrYztE-hjdxfnoGO5EQQKZAT9HpEZNJjFl8ImlkZ8RykGufQ_buf7n-NF3BQ6UulKR8uoV1uPuQV-teSXSvFfAPfg39B
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_G_JhvOhWdX1Okb0Vpk3Z9KEK_6HTthmtlb6NpM1DGVmxF_O-9htb5oq8JJHch97v7XXIJwC0juq4xbSGnSKhlktFUTtARyCxVOSfMUBitaoeDUPNj8jijsxa8NbUw4p3QT_E4IlpUivZeCrzON0ksR9ytLO7YKzatH7zIdKSaHaN3wx0rOZbpTsbO2JZs24ynUviMsa6qUUWnFsL1FobYemUN7otVVaXkv12Ktw_bExxtVR5Ai6-60LGbn9e6sBvUB95d2BE3NNMCG2srLA7hZlgVdTSotfzqJwK0-vl6iawSMSDjR3DtuZHtyzjt_EfHeTzdSKgeQxu5Pz-BPpKTjPAMBR4MSJZwgynpIqOJkhADlaCn0Pt7nN5_nVfQ8aNgNB8Nw6cz2KvWTqQs78-hXb5_8Av0tSW7FIv0DQIfgjQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Immunologically+active+polypeptide&rft.inventor=Scoville%2C+Craig+D&rft.date=2019-07-30&rft.externalDBID=B2&rft.externalDocID=US10365275B2